Endovanilloids: Putative endogenous ligands of transient receptor potential vanilloid 1 channels

European Journal of Biochemistry

Volumn 271, Issue 10, 2004, Pages 1827-1834

  Van Der Stelt, Mario ^a   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

Anandamide; Arachidonic acid; Cannabinoid; Lipid; Signaling; TRP; VR1

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROPEROXYARACHIDONIC ACID; ANANDAMIDE; ARACHIDONIC ACID; BRADYKININ; CANNABINOID; CAPSAICIN; CATION CHANNEL; ION CHANNEL; LIGAND; LIPID; LIPOXYGENASE; N ARACHIDONOYLDOPAMINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ACIDITY; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; HUMAN; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; NONHUMAN; PEPPER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SHORT SURVEY;

ANIMALS; ARACHIDONIC ACIDS; DOPAMINE; HUMANS; ION CHANNELS; LIGANDS; LIPOXYGENASE; POLYUNSATURATED ALKAMIDES; RECEPTORS, DRUG;

CAPSICUM; CAPSICUM ANNUUM VAR. ANNUUM;

EID: 2442636258     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04081.x     Document Type: Short Survey

References (80)

1. Caterina, M., Schumacher, M., Tominaga, M., Rosen, T., Levine, J. & Julius, D. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824.
2. Szallasi, A. & Blumberg, P.M. (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 51, 159-212.
3. Caterina, M., Leffler, A., Malmberg, A., Martin, W., Trafton, J., Petersen-Zeitz, K., Koltzenburg, M., Kasbaum, A. & Julius, D. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288, 306-313.
4. Davis, J.B., Gray, J., Gunthorpe, M.J., Hatcher, J.P., Davey, P.T., Overend, P., Harries, M.H., Latcham, J., Clapham, C., Atkinson, K., et al. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405, 183-187.
5. Caterina, M.J. (2003) Vanilloid receptors take a TRP beyond the sensory afferent. Pain 105, 5-9.
6. Mezey, E., Toth, Z.E., Cortright, D.N., Arzubi, M.K., Krause, J.E., Elde, R., Guo, A., Blumberg, P.M. & Szallasi, A. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1, and VR1-like inmmunoreactivity, in the central nervous system of the rat and human. Proc. Natl Acad. Sci. USA 97, 3655-3660.
7. 3H]-Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 995, 176-183.
8. De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J.B., Finazzi-Agro, A. & Di Marzo, V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276, 12856-12863.
9. Jordt, S.E.J. (2002) Molecular basis for species-specific sensitivity to 'hot' chili peppers. Cell 108, 421-430.
10. Huang, S.M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T.J., Krey, J.F., Chu, C.J., et al. (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl Acad. Sci. USA. 99, 8400-8405.
11. Chu, C.J., Huang, S.M., De Petrocellis, L., Bisogno, T., Ewing, S.A., Miller, J.D., Zipkin, R.E., Daddario, N., Appendino, G., Di Marzo, V. & Walker, J.M. (2003) N-oleoyldopamine: a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. 278, 13633-13639.
12. Hillard, C. & Jarrahian, A. (2003) Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol. 140, 802-808.
13. Toth, A., Kedei, N., Wang, Y. & Blumberg, P.M. (2003) Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. Life Sci. 73, 487-498.
14. Di Marzo, V., De Petrocellis, L., Fezza, F., Ligresti, A. & Bisogno, T. (2002) Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66, 377-391.
15. Harrison, S., De Petrocellis, L., Trevisani, M., Benvenuti, F., Bifulco, M., Geppetti, P. & Di Marzo, V. (2003) Capsaicin-like effects or N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder. Eur. J. Pharmcol. 475, 107-114.
16. Hwang, S.W., Cho, H., Kwak, J., Lee, S.Y., Kang, C.J., Jung, J., Cho, S., Min, K.H., Suh, Y.G., Kim, D. & Oh, U. (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl Acad. Sci. USA. 97, 6155-6160.
17. Funk, C.D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875.
18. Kuhn, H., Walther, M. & Kuban, R.J. (2002) Mammalian arachidonate 15-lipoxygenases. Structure, function and biological implications. Prostaglandins Other Lipid Mediat. 68-69, 263-290.
19. Yoshimoto, T. & Takahashi, Y. (2002) Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat. 68-69, 245-262.
20. Nishiyama, M., Okamoto, H., Watanabe, T., Hori, T., Hada, T., Ueda, N., Yamamoto, S., Tsukamoto, H., Watanabe, K. & Kirino, T. (1992) Localization of arachidonate 12-lipoxygenase in canine brain tissues. J. Neurochem. 58, 1395-1400.
21. Nishiyama, M., Watanabe, T., Ueda, N., Tsukamoto, H. & Watanabe, K. (1993) Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J. Histochem. Cytochem. 41, 111-117.
22. Shin, J., Cho, H., Hwang, S.W., Jung, J., Shin, C.Y., Lee, S.Y., Kim, S.H., Lee, M.G., Choi, Y.H., Kim, J., et al. (2002) Bradykinin-12-lipoxygenase- VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl Acad. Sci. USA 99, 10150-10155.
23. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A. & Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87.
24. Hampson, A.J., Hill, W.A., Zan-Phillips, M., Makriyannis, A., Leung, E., Eglen, R.M. & Bornheim, L.M. (1995) Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor. Biochim. Biophys. Acta 1259, 173-179.
25. Edgemond, W.S., Hillard, C.J., Falck, J.R., Kearn, C.S. & Campbell, W.B. (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivalion. Mol. Pharmacol. 54, 180-188.
26. Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K. et al. (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim. Biophys. Acta 1254, 127-134.
27. van der Stelt, M., van Kuik, J.A., Bari, M., van Zadelhoff, G., Leeflang, B.R., Veldink, G.A., Finazzi-Agro, A., Vliegenthart, J.F. & Maccarrone, M. (2002) Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J. Med. Chem. 45, 3709-3720.
28. Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G.A., Vliegenthart, J.F. & Finazzi Agro, A. (1998) Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem. 273, 32332-32339.
29. Craib, S.J., Ellington, H.C., Pertwee, R.G. & Ross, R.A. (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol. 134, 30-37.
30. Kagaya, M., Lamb, J., Robbins, J., Page, C.P. & Spina, D. (2002) Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol. 137, 39-48.
31. De Petrocellis, L., Harrison, S., Bisogno, T., Tognetto, M., Brandi, I., Smith, G.D., Creminon, C., Davis, J.B., Geppetti, P. & Di Marzo, V. (2001) The vanilloid receptor (VR1) -mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem. 77, 1660-1663.
32. McLean, P.G., Aston, D., Sarkar, D. & Ahluwalia, A. (2002) Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ. Res. 90, 465-472.
33. Hwang, S.W. & Oh, U. (2002) Hot channels in airways: pharmacology of the vanilloid receptor. Curr. Opin. Pharmacol. 2, 235-242.
34. Kollarik, M. & Undem, B. (2003) Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wildtype and TRPV1-/- mice. J. Physiol., 555, 115-123.
35. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
36. Di Marzo, V., Melck, D., Bisogno, T. & De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521-528.
37. Schmid, H.H. (2000) Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem. Phys. Lipids 108, 71-87.
38. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D. & Hogestatt, E.D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457.
39. Smart, D., Gunthorpe, M.J., Jerman, J.C., Nasir, S., Gray, J., Muir, A.I., Chambers, J.K., Randall, A.D. & Davis, J.B. (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129, 227-230.
40. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.C. & Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
41. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T. & Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305.
42. Ahluwalia, J.Y.M., Urban, L., Bevan, S. & Nagy, I. (2003) Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem. 84, 585-591.
43. Van der Stelt, M. & Di Marzo, V. (2004) Metabolic fate of endocannabinoids. Current Neuropharm. 2, 37-48.
44. Hillard, C.J., Edgemond, W.S., Jarrahian, A. & Campbell, W.B. (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69, 631-638.
45. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A. & Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094-1097.
46. De Petrocellis, L., Bisogno, T., Davis, J.B., Pertwee, R.G. & Di Marzo, V. (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 483, 52-56.
47. Lopez-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S., Fowler, C.J., Tiger, G., de Lago, E., Fernandez-Ruiz, J. & Ramos, J.A. (2003) Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J. Med. Chem. 46, 1512-1522.
48. Ortar, G.L.A., De Petrocellis, L., Morera, E. & Di Marzo, V. (2003) Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem. Pharmacol. 65, 1473-1481.
49. Deutsch, D.G., Ueda, N. & Yamamoto, S. (2002) The fatty acid amide hydrolase (FAAH). Prostaglandins Leukot. Essent. Fatty Acids 66, 201-210.
50. Kozak, K.R. & Marnett, L.J. (2002) Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids 66, 211-220.
51. Cravatt, B.F., Demarest, K., Patricelli, M.P., Bracey, M.H., Giang, D.K., Martin, B.R. & Lichtman, A.H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 98, 9371-9376.
52. Egertova, M., Giang, D.K., Cravatt, B.F. & Elphick, M.R. (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. R. Soc. Lond. B Biol Sci. 265, 2081-2085.
53. Ross, R.A. (2003) Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140, 790-801.
54. Ross, R.A., Coutts, A.A., McFarlane, S.M., Anavi-Goffer, S., Irving, A.J., Pertwee, R.G., MacEwan, D.J. & Scott, R.H. (2001) Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40, 221-232.
55. De Petrocellis, L., Davis, J.B. & Di Marzo, V. (2001) Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett. 506, 253-256.
56. Smart, D., Jerman, J.C., Gunthorpe, M.J., Brough, S.J., Ranson, J., Cairns, W., Hayes, P.D., Randall, A.D. & Davis, J.B. (2001) Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol. 417, 51-58.
57. Andersson, D.A., Adner, M., Hogestatt, E.D. & Zygmunt, P.M. (2002) Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol. Pharmacol. 62, 705-713.
58. Ralevic, V., Kendall, D.A., Jerman, J.C., Middlemiss, D.N. & Smart, D. (2001) Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur. J. Pharmacol. 424, 211-219.
59. Szolcsanyi, J. (2000) Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? Trends Pharmacol Sci. 21, 41-42.
60. Di Marzo, V., Blumberg, P.M. & Szallasi, A. (2002) Endovanilloid signaling in pain. Curr. Opin. Neurobiol. 12, 372-379.
61. Trevisani, M., Smart, D., Gunthorpe, M.J., Tognetto, M., Barbieri, M., Campi, B., Amadesi, S., Gray, J., Jerman, J.C., Brough, et al. (2002) Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat. Neurosci. 5, 546-551.
62. Chuang, H.H., Prescott, E.D., Kong, H., Shields, S., Jordt, S.E., Basbaum, A.I., Chao, M.V. & Julius, D. (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5),P2-mediated inhibition. Nature 411, 957-962.
63. Premkumar, L.S. & Ahern, G.P. (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408, 985-990.
64. Tominaga, M., Wada, M. & Masu, M. (2001) Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl Acad. Sci. USA 98, 6951-6956.
65. Bonnington, J. & McNaughton, P. (2003) Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J. Physiol. 551, 433-446.
66. Ahern, G. & Premkumar, L. (2002) Voltage-dependent priming of rat vanilloid receptor: effects of agonist and protein kinase C activation. J. Physiol. 545, 441-451.
67. Numazaki, M., Tominaga, T., Takeuch, K., Murayama, N., Toyooka, H. & Tominaga, M. (2003) Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc. Natl Acad. Sci. USA 100, 8002-8006.
68. McVey, D., Schmid, P., Schmid, H. & Vigna, S. (2003) Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J. Pharmacol. Exp. Ther. 304, 713-722.
69. Smart, D., Jonsson, K.O., Vandevoorde, S., Lambert, D.M. & Fowler, C.J. (2002) 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J. Pharmacol. 136, 452-458.
70. Ahern, G. (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J. Biol. Chem. 278, 30429-30434.
71. Szallasi, A. (2002) Vanilloid (capsaicin) receptors in health and disease. Am. J. Clin. Pathol. 118, 110-121.
72. Hogestatt, E.D. & Zygmunt, P.M. (2002) Cardiovascular pharmacology of anandamide. Prostaglandins Leukot. Essent. Fatty Acids 66, 343-351.
73. Al-Hayani, A., Wease, K.N., Ross, R.A., Pertwee, R.G. & Davies, S.N. (2001) The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41, 1000-1005.
74. Marinelli, S., Di Marzo, V., Berretta, N., Matias, I., Maccarrone, M., Bernardi, G. & Mercuri, N.B. (2003) Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci. 23, 3136-3144.
75. Lastres-Becker, I., Hansen, H.H., Berrendero, F., De Miguel, R., Perez-Rosado, A., Manzanares, J., Ramos, J.A. & Fernandez-Ruiz, J. (2002) Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Synapse 44, 23-35.
76. Lastres-Becker, I., de Miguel, R., De Petrocellis, L., Makriyannis, A., Di Marzo, V. & Fernandez-Ruiz, J. (2003) Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease, J. Neurochem. 84, 1097-1109.
77. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S.C., Cascio, M.G., Gutierrez, S.O., van der Stelt, M. et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84-88.
78. Veldhuis, W.B., Van Der Stelt, M., Wadman, M.W., Van Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G.A., Vliegenthart, J.F., Bar, P.R., Nicolay, K. & Di Marzo, V. (2003) Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J. Neurosci. 23, 4127-4133.
79. van der Stelt, M., Veldhuis, W.B., Maccarrone, M., Bar, P.R., Nicolay, K., Veldink, G.A., Di Marzo, V. & Vliegenthart, J.F. (2002) Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol. Neurobiol. 26, 317-346.
80. Ahluwalia, J., Urban, L., Bevan, S. & Nagy, I. (2003) Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci. 7, 2611-2618.